Results 161 to 170 of about 124,134 (216)

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

Radiologic 3D tumor volume predicts cervical metastasis in oral squamous cell carcinoma. [PDF]

Clin Oral Investig
Schmitz A, Corneo V, Rendenbach C, Doll C, Elsholtz F, Kreutzer K, Mrosk F, Alfertshofer M, Heiland M, Koerdt S.   +9 more
europepmc   +1 more source

Mass Spectrometry Insights Into Post‐Translational Modifications in Extracellular Vesicles

Mass Spectrometry Reviews, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are membrane‐enclosed structures secreted by virtually all living cells, serving as essential mediators of intercellular communication in both physiological and pathological processes. There is growing interest in their potential applications as biomarkers, therapeutic targets, and drug delivery systems, which ...
Dávid Virág, Krisztián Márk Karvaly, Alexandra Molnár, Mirjam Balbisi, Júlia Németh, Lilla Turiák   +5 more
wiley   +1 more source

RHEBL1 expression is activated by the Oct4-Sox2 complex in oral squamous cell carcinoma. [PDF]

Funct Integr Genomics
Qiu F, Chen Y, Li P, Chen Z, Lam AK, Liang Y, Sun X, Jiang Q, Qiao B.   +8 more
europepmc   +1 more source

Artificial Intelligence for Identifying Tumor‐Reactive CD8+ T Cells: Biological Principles, Computational Advances, and Future Directions

Med Research, EarlyView.
This review details a three‐stage paradigm shift for tumor‐reactive CD8+ T‐cell identification: decoding transcriptomic states, deciphering clonal functional efficacy, and molecular‐level therapeutic TCR design. Addressing translational hurdles and generative AI “scientific blind spots”—such as missing catch bonds—we present a visionary roadmap.
Chao Yang, Yingying Sun, Yan Zhang, Yifen Shi, Zhiwen Shi   +4 more
wiley   +1 more source

Non-Pharmacological Treatments for Oral Carcinogenesis: From Oral Lichen Planus to Oral Squamous Cell Carcinoma. [PDF]

Cancers (Basel)
Re F, Scilla F, Labanca M, Russo D, Gioco G, Favero G, Rezzani R.   +6 more
europepmc   +1 more source

Organoid Coculture Models for Cancer Research and Immunotherapy

Med Research, EarlyView.
This review summarizes organoid coculture platforms, including submerged Matrigel culture, air–liquid interface, microfluidic/organoid‐on‐a‐chip, and 3D bioprinting, for reconstructing the tumor microenvironment to study tumor–stroma/immune crosstalk, evaluate immunotherapies, and enable drug screening.
Zhuo Yang, Huihui Yang, Guangxin Li, Guobang Liu, Zhulan Chen, Wenzhi Tian, Meiyang Huang, Xiaoling Liu, Yongsheng Zhao, Dong Chen   +9 more
wiley   +1 more source

Biomarkers in oral squamous cell carcinoma: a systematic review. [PDF]

Med Oral Patol Oral Cir Bucal
López-Galindo M, Sousa-Roques MD.
europepmc   +1 more source

Margin Status and Local Recurrence in Early‐Stage Oral‐Cavity Squamous Cell Carcinoma: Analysis of Reresection Outcomes

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To assess the impact of surgical margin status and re‐resection on local recurrence (LR) in early‐stage oral cavity squamous cell carcinoma (OCSCC). Study Design Retrospective analysis of 352 patients with cT1‐2N0 OCSCC. Setting Tertiary care center from 2005 to 2024.
Hannah J. Brown, Naomi C. Wang, Rahul Alapati, Uma Ramesh, Ameen M. Amanian, Andrés M. Bur   +5 more
wiley   +1 more source

Evolving Principles for Oral Squamous Cell Carcinoma Screening Programs. [PDF]

Cancers (Basel)
Santos-Silva AR, Epstein JB, Kowalski LP, Esteves-Pereira TC, Prado-Ribeiro AC, Martins MD, Lopes MA, Sollecito TP.   +7 more
europepmc   +1 more source